• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·CVS
Share

CVS Health Corporation Stocks

$ 101.96Last Updated 12.06.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

$ 128.21B

$ 101.96
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Slightly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

07.04.2026 15:34

Morning in New York: Trump's deadline for Iran in focus

17.02.2026 19:15

'A once-in-a-generation chance'. Why JPMorgan advises to buy unpopular quality stocks

27.01.2026 15:34

Morning in New York: trading will take place in a turbulent zone

27.01.2026 10:58

Insurers' stocks in the U.S. collapsed over plans to keep Medicare payment rates unchanged

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

CVS Health Corporation is a prominent healthcare services provider operating across the United States. The company's Health Care Benefits division delivers a range of health insurance offerings, including traditional plans, voluntary coverage, and consumer-directed options, alongside associated services. Its diverse clientele spans employer organizations, private individuals, university students, part-time and hourly staff, various health plans, healthcare providers, government bodies, state-sponsored programs, labor unions, and individuals living abroad. Through its Pharmacy Services segment, CVS Health manages pharmacy benefits, offering comprehensive solutions such as designing and administering plans, managing drug formularies, overseeing retail pharmacy networks, and providing mail-order, specialty pharmacy, and infusion services. This segment also delivers clinical support and helps manage disease and medical expenditures. It serves a broad array of clients, including employers, insurance carriers, trade unions, government employee groups, health plans, prescription drug programs, Medicaid managed care organizations, and plans available on both public and private health insurance marketplaces, in addition to other health benefit plan sponsors and individual consumers. Operationally, this segment encompasses specialty retail pharmacies, specialty mail-order services, general mail-order dispensing pharmacies, compounding pharmacies, and facilities dedicated to infusion and enteral nutrition support. The Retail/LTC (Long-Term Care) segment is responsible for selling both prescription and over-the-counter medications, consumer health and beauty items, and personal care products. It also delivers healthcare services via its MinuteClinic walk-in medical clinics. Furthermore, this segment handles the distribution of prescription drugs and offers pharmacy consulting along with other supplementary services to long-term care facilities and various other care environments. As of December 31, 2021, CVS Health boasted approximately 9,900 retail outlets and 1,200 MinuteClinic locations. This network is complemented by online retail pharmacy platforms, LTC pharmacies, and on-site pharmacies. Originally established in 1963 and headquartered in Woonsocket, Rhode Island, the company was known as CVS Caremark Corporation before officially rebranding to CVS Health Corporation in September 2014.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of CVS is 106 and suggests 4% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sug

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 22:31

U.S. and Iran to sign agreement on June 14, Strait of Hormuz to reopen - Trump

13.06.2026 16:01

Highlights in small-caps: record IPO in biotech, Wizz Air success, SpaceX effect

13.06.2026 13:01

An investment idea for all times, IPO of the year and how to keep emotions in check in the stock market

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026